Skip to main content
PureTech Health plc logo

PureTech Health plc — Investor Relations & Filings

Ticker · PRTC ISIN · GB00BPVG5C82 LEI · 213800LVPDNO2Z9T9I39 IL Manufacturing
Open in API
Filings indexed 1,319 across all filing types
Latest filing 2023-10-16 Transaction in Own Shar…
Country GB United Kingdom
Listing IL PRTC

About PureTech Health plc

https://puretechhealth.com/

PureTech Health is a clinical-stage biotherapeutics company dedicated to discovering, developing, and commercializing new classes of medicine for devastating diseases. The company's research and development engine focuses on advancing novel treatments by enhancing on-target efficacy, improving tolerability, or enabling oral administration of therapeutics with validated mechanisms. Its pipeline includes wholly-owned therapeutic candidates targeting a range of conditions, including idiopathic pulmonary fibrosis, neuropsychiatric disorders, and various cancers.

Recent filings

Filing Released Lang Actions
Transaction in Own Shares
Transaction in Own Shares Classification · 99% confidence The document explicitly states its purpose in the title/header section: "PureTech Health plc Transaction in Own Shares". It details the purchase of ordinary shares as part of a "Share Buyback Programme" on a specific date (13 October 2023) and provides the volume, highest, lowest, and VWAP prices. This activity directly corresponds to the definition of 'Transaction in Own Shares'. The filing is also identified as an 'RNS Number', but the core content is the transaction itself, making 'POS' the most specific classification over the general 'RNS' fallback.
2023-10-16 English
Transaction in Own Shares
Transaction in Own Shares Classification · 100% confidence The document explicitly states its purpose in the title section: 'Transaction in Own Shares' and details the purchase of ordinary shares as part of a 'Share Buyback Programme'. It provides specific transaction dates, volumes, and prices. This directly corresponds to the definition of 'Transaction in Own Shares' (Code: POS). The RNS Number (9967P) confirms it is a regulatory announcement, but the content is specific enough to use the dedicated POS code.
2023-10-13 English
Transaction in Own Shares
Transaction in Own Shares Classification · 100% confidence The document explicitly states its purpose in the title section: 'PureTech Health PLC Transaction in Own Shares'. It details the purchase of ordinary shares as part of a 'Share Buyback Programme' on a specific date (11 October 2023), including volume, high, low, and VWAP prices. This directly corresponds to the definition of 'Transaction in Own Shares' (POS), which covers company buying back or selling its own shares (share repurchase/issuance). The RNS Number (8542P) indicates it is a regulatory announcement, but the content is specific enough to map to POS rather than the general RNS fallback.
2023-10-12 English
New LYT-100 Data from Phase 1 Trials at Conference
Legal Proceedings Report Classification · 99% confidence The document begins with an RNS Number (6939P) and a date (11 October 2023), indicating it is a regulatory announcement disseminated via the Regulatory News Service (RNS). The content is a press release detailing the presentation of clinical data for a drug (LYT-100) at a medical conference (CHEST Annual Meeting). It summarizes key findings, quotes executives and investigators, and includes forward-looking statements referencing a Form 20-F filing. This structure—a news announcement about clinical/business developments distributed via RNS—is characteristic of a general regulatory announcement that doesn't fit the specific categories like Earnings Release (ER), Interim Report (IR), or Capital Update (CAP). Since it is a formal announcement distributed through the RNS system and serves as a general update, the most appropriate classification is Regulatory Filings (RNS), as it is not a primary financial report itself.
2023-10-11 English
Transaction in Own Shares
Transaction in Own Shares Classification · 100% confidence The document explicitly states its purpose in the title section: "Transaction in Own Shares". It details the purchase of ordinary shares as part of a "Share Buyback Programme" on a specific date (10 October 2023), including volume, high, low, and VWAP prices. This directly corresponds to the definition of 'Transaction in Own Shares' (Code: POS). The RNS Number and the reference to FCA rules confirm it is a regulatory disclosure related to share capital changes, specifically repurchases.
2023-10-11 English
Transaction in Own Shares
Transaction in Own Shares Classification · 99% confidence The document explicitly states its purpose in the title section: "Transaction in Own Shares". It details the purchase of ordinary shares as part of a "Share Buyback Programme" on a specific date (9 October 2023), including volume, highest, lowest, and VWAP prices. This directly corresponds to the definition of 'Transaction in Own Shares' (Code: POS), which covers the company buying back or selling its own shares (share repurchase/issuance). The RNS Number format also suggests a regulatory disclosure, but the content is highly specific to share repurchase activity.
2023-10-10 English

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.